Publications by authors named "Bernice Benoit"

Claim this Profile
H
High-Throughput Sequencing and Estimated Relapse Risk in Patients With Sézary Syndrome.
Jeffrey D Weiner, David M Weiner, Bernice Benoit, Jessica E Teague, Rachael A Clark

JAMA Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological characterization of vacuolar tauopathy associated with VCP D395G.
Ryohei Watanabe, John D Papatriantafyllou, Kengo Maeda, Geoffrey K Aguirre, Masahiro Ando, Bernice Benoit

Alzheimers Dement· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TCF1 and Tox define different subsets of CD4 T cells in patients with Sézary syndrome.
Maria Wysocka, Neha Jariwala, Kevin Zhang, Bernice Benoit, Alain H Rook

Leuk Lymphoma· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Total Skin Electron Beam Therapy as Part of a Multimodality Regimen for Treatment of Sézary Syndrome: Clinical, Immunologic, and Molecular Analysis.
Joseph S Durgin, Neha N Jariwala, Maria Wysocka, Kevin K Zhang, Amit Maity, Bernice Benoit

JAMA Dermatol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD164 identifies CD4 T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.
Bernice M Benoit, Neha Jariwala, Geraldine O'Connor, Landon K Oetjen, Timothy M Whelan

Arch Dermatol Res· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TIGIT and Helios Are Highly Expressed on CD4 T Cells in Sézary Syndrome Patients.
Neha Jariwala, Bernice Benoit, Andrew V Kossenkov, Landon K Oetjen, Timothy M Whelan

J Invest Dermatol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma.
Alain H Rook, Joel M Gelfand, Maria Wysocka, Andrea B Troxel, Bernice Benoit

Blood· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities.
Filiberto Cedeno-Laurent, Elisha M Singer, Maria Wysocka, Bernice M Benoit, Carmela C Vittorio

Clin Immunol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.
Maria Wysocka, Andrew V Kossenkov, Bernice M Benoit, Andrea B Troxel, Elisha Singer

J Invest Dermatol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus.
Elisha M Singer, Daniel B Shin, Leigh A Nattkemper, Bernice M Benoit, Rachel S Klein

J Invest Dermatol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The histone deacetylase inhibitor, romidepsin, suppresses cellular immune functions of cutaneous T-cell lymphoma patients.
Michael J Kelly-Sell, Youn H Kim, Suzanne Straus, Bernice Benoit, Cameron Harrison

Am J Hematol· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: implications for therapy of cutaneous T-cell lymphoma.
Sasha Stephen, Kelly A Morrissey, Bernice M Benoit, Ellen J Kim, Carmela C Vittorio

Am J Hematol· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic enhancement of cellular immune responses by the novel Toll receptor 7/8 agonist 3M-007 and interferon-γ: implications for therapy of cutaneous T-cell lymphoma.
Maria Wysocka, Noor Dawany, Bernice Benoit, Andrew V Kossenkov, Andrea B Troxel

Leuk Lymphoma· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression.
Sara Samimi, Bernice Benoit, Katherine Evans, E John Wherry, Louise Showe

Arch Dermatol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.
Alain H Rook, Bernice Benoit, Ellen J Kim, Carmela C Vittorio, Aleksandra Anshelevich

Clin Lymphoma Myeloma Leuk· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and in vitro resistance to bexarotene in adult T-cell leukemia: loss of RXR-alpha receptor.
Julie H Lin, Ellen J Kim, Anand Bansal, John Seykora, Stephen K Richardson, Bernice Benoit

Blood· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-21 enhances antitumor responses without stimulating proliferation of malignant T cells of patients with Sézary syndrome.
Jessica S Yoon, Sarah M Newton, Maria Wysocka, Andrea B Troxel, Stephen D Hess, Bernice M Benoit

J Invest Dermatol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bexarotene blunts malignant T-cell chemotaxis in Sezary syndrome: reduction of chemokine receptor 4-positive lymphocytes and decreased chemotaxis to thymus and activation-regulated chemokine.
Stephen K Richardson, Sarah B Newton, Tami L Bach, Jeanne B Budgin, Bernice M Benoit

Am J Hematol· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.
Maria Wysocka, Sarah Newton, Bernice M Benoit, Camille Introcaso, Aidan S Hancock

Clin Lymphoma Myeloma· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apoptotic responses to all-trans retinoic acid of targretin-resistant, malignant, CD4+ peripheral blood T cells from patients with Sezary syndrome.
Sarah B Newton, Jessica S Yoon, Bernice M Benoit, Maria Wysocka, Alain H Rook

Arch Dermatol· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A role for regulatory T cells in cutaneous T-Cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection.
Patrick T Walsh, Bernice M Benoit, Maria Wysocka, Nicole M Dalton, Laurence A Turka

J Invest Dermatol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunopathogenesis and therapy of cutaneous T cell lymphoma.
Ellen J Kim, Stephen Hess, Stephen K Richardson, Sara Newton, Louise C Showe, Bernice M Benoit

J Clin Invest· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biological effects of bexarotene in cutaneous T-cell lymphoma.
Jeanne B Budgin, Stephen K Richardson, Sarah B Newton, Maria Wysocka, Mohamed H Zaki, Bernice Benoit

Arch Dermatol· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15.
Maria Wysocka, Bernice M Benoit, Sarah Newton, Livio Azzoni, Luis J Montaner

Blood· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of cytokines, fusion proteins and antibodies to treat cutaneous T-cell lymphoma.
Alain H Rook, Karen S McGinnis, Stephen K Richardson, Jeanne B Budgin, Maria Wysocka, Bernice M Benoit

Dermatol Ther· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis